FMC (NYSE:FMC) VP Jacqueline Scanlan Sells 4,930 Shares of Company Stock

FMC Corporation (NYSE:FMC) VP Jacqueline Scanlan sold 4,930 shares of FMC stock in a transaction that occurred on Tuesday, November 3rd. The shares were sold at an average price of $6.55, for a total value of $32,291.50. Following the sale, the vice president directly owned 58,628 shares in the company, valued at $384,013.40. The trade was a 7.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

FMC Price Performance

Shares of FMC traded down $0.36 during mid-day trading on Thursday, reaching $6.05. The company had a trading volume of 5,310,462 shares, compared to its average volume of 4,428,864. FMC Corporation has a twelve month low of $4.37 and a twelve month high of $18.29. The company has a debt-to-equity ratio of 416.31, a current ratio of 1.66 and a quick ratio of 1.18. The company’s 50-day moving average is $8.83 and its 200-day moving average is $12.33. The company has a market capitalization of $941.92 million, a P/E ratio of -0.18 and a beta of 0.50.

FMC (NYSE:FMC) last posted its earnings results on Thursday, October 29th. The basic materials company reported ($4.41) EPS for the quarter, missing the consensus estimate of $0.08 by ($4.49). The company had revenue of $105.90 million for the quarter, compared to the consensus estimate of $487.63 million. FMC had a negative return on equity of 30.77% and a negative net margin of 151.18%. FMC’s quarterly revenue was down 80.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.89 EPS. On average, equities analysts anticipate that FMC Corporation will post -3.71 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Morgan Stanley cut their price objective on FMC from $12.00 to $8.00 and set an “equal weight” rating for the company in a report on Monday. Citigroup upped their target price on shares of FMC from $6.00 to $7.00 and gave the stock a “neutral” rating in a report on Tuesday. JPMorgan Chase & Co. dropped their target price on shares of FMC from $16.00 to $12.00 and set a “neutral” rating for the company in a research report on Friday, July 31st. Wall Street Zen raised shares of FMC from a “sell” rating to a “hold” rating in a report on Saturday, August 1st. Finally, Mizuho set a $10.00 price objective on shares of FMC in a report on Thursday, October 15th. Three analysts have rated the stock with a Buy rating, nine have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Reduce” and a consensus price target of $10.71.

FMC News Roundup

Here are the key news stories impacting FMC this week:

• Positive Sentiment: Citigroup forecast strong potential price appreciation for FMC shares, offering a bullish view amid widespread analyst caution. Article: Citigroup Forecasts Strong Price Appreciation for FMC Stock
• Negative Sentiment: UBS Group, Royal Bank of Canada and Morgan Stanley each cut their FMC price targets, signaling reduced expectations for the stock. The reports’ headlines do not specify the revised targets. UBS article RBC article Morgan Stanley article
• Negative Sentiment: A separate report said FMC shares fell following an analyst downgrade, reinforcing near-term selling pressure. Article: FMC Shares Down After Analyst Downgrade
• Negative Sentiment: Pomerantz LLP announced an investigation into potential claims on behalf of FMC investors. The announcement is not a finding of wrongdoing, but could add reputational and legal uncertainty. Article: Pomerantz Law Firm Investigates Claims on Behalf of FMC Investors
• Negative Sentiment: A retrospective article highlighted FMC’s steep decline after Goldman Sachs had previously maintained a Buy recommendation, underscoring the risks of the company’s prolonged share-price weakness. Article: Goldman Sachs Said Buy This Stock a Year Ago. Now It’s Lost 61%

Hedge Funds Weigh In On FMC

A number of institutional investors and hedge funds have recently bought and sold shares of FMC. Bank of New York Mellon Corp bought a new stake in shares of FMC during the second quarter worth $8,498,000. AXQ Capital LP increased its stake in shares of FMC by 109.9% in the second quarter. AXQ Capital LP now owns 366,661 shares of the basic materials company’s stock valued at $4,217,000 after buying an additional 191,945 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of FMC by 142.4% in the second quarter. Wellington Management Group LLP now owns 235,089 shares of the basic materials company’s stock valued at $2,704,000 after buying an additional 138,098 shares in the last quarter. Ethic Inc. raised its holdings in shares of FMC by 38.9% in the third quarter. Ethic Inc. now owns 168,271 shares of the basic materials company’s stock valued at $1,501,000 after buying an additional 47,113 shares during the last quarter. Finally, Public Employees Retirement System of Ohio bought a new position in shares of FMC in the second quarter valued at about $1,175,000. Institutional investors and hedge funds own 91.86% of the company’s stock.

About FMC

FMC Corporation (NYSE: FMC) is an agricultural sciences company that develops and markets crop protection products and technologies. Its portfolio is designed to help farmers manage weeds, insects and diseases that can affect crop yields and quality.

The company’s products include herbicides, insecticides, fungicides, biological crop protection products and seed treatment solutions. FMC also develops crop health technologies and digital tools intended to support more precise and efficient agricultural applications.

FMC serves farmers, agricultural retailers and distributors in major farming regions around the world, with products used across a broad range of crops.